Understanding the Priority: Safety vs. Pharmacological Intervention
In the context of NCLEX-RN prioritization, this question tests your ability to distinguish between a physiological intervention and a direct safety intervention. Hepatic encephalopathy (HE) is a neuropsychiatric syndrome caused by liver failure and portosystemic shunting. While the underlying pathophysiology involves hyperammonemia and systemic inflammation, the immediate clinical manifestation that poses a threat to the client is impaired cognition, altered level of consciousness, and neuromuscular dysfunction . These deficits directly lead to a high risk of falls and physical injury
[4].
Pathophysiology: Why the Brain is Vulnerable
The liver's inability to metabolize ammonia and the synergistic role of systemic inflammation lead to cerebral edema and astrocyte dysfunction . This manifests clinically as:
- Disorientation and confusion
- Asterixis (flapping tremor) and motor incoordination
- Somnolence progressing to coma
These neurological changes mean the client cannot maintain their own safety. A lapse in judgment or a sudden loss of motor control can result in a fall from bed, pulling out lines, or other traumatic injuries. Research specifically identifies falls as a "major threat to the well-being of patients with cirrhosis," highlighting the need for interventions that directly mitigate this physical risk
[4].
Analyzing the Answer Choices Using the Nursing Process
1.
Administer lactulose as prescribed to reduce ammonia levels: Lactulose is the first-line pharmacological therapy for HE, working by acidifying the colon to trap and expel ammonia . However, it is a physician-prescribed intervention that takes time to lower ammonia levels and resolve neurological symptoms. In the NCLEX setting, while important, it does not address the immediate risk of the client falling out of bed right now.
2.
Implement safety measures to prevent injury: This is the correct priority. It directly addresses the immediate risk of injury from the client's altered mental and motor status. This involves placing the bed in the lowest position, padding side rails, and providing frequent monitoring. This action protects the client from harm while the underlying medical treatment (like lactulose) takes effect. The clinical trial LIVE-SMART is specifically designed to test interventions like these to reduce falls in this population, underscoring the clinical significance of this safety risk
[4].
3.
Monitor serum ammonia levels every 8 hours: While monitoring is a key nursing responsibility and helps evaluate the effectiveness of therapy, it is an assessment action. It does not prevent the client from falling out of bed in the next 5 minutes. In prioritization, an action that prevents immediate harm (safety) takes precedence over an assessment that gathers data for future actions.
4.
Restrict protein intake to 20-30 grams per day: Historically, protein restriction was a mainstay of HE management. However, current guidelines have moved away from prolonged, severe protein restriction because it can worsen malnutrition and sarcopenia, which paradoxically increases ammonia production from muscle breakdown . Modern management focuses on maintaining adequate protein intake (often with a shift to vegetable and dairy proteins) while treating the precipitating factors. This is a long-term nutritional strategy, not an immediate safety priority.
Clinical Reasoning and NCLEX Strategy
The NCLEX frequently tests the hierarchy of priorities: safety always comes first. When a client has a condition that directly impairs their ability to protect themselves, physical safety measures are the most immediate and independent nursing action. Administering a medication, while critical, is a dependent intervention that treats the underlying cause but does not instantly remove the immediate danger. The correct sequence in practice is to first ensure the client is safe from falls and injury, and then administer the prescribed lactulose to reverse the encephalopathic process [1,4].
References (research sources)
- [4]
LIVE-SMART: A sequential, multiple assignment randomized trial to reduce falls in cirrhosis.RCT/clinical trialTapper EB, Nikirk S, Evon DM, Asrani S, Bloom P, Hynes JW, Alber JM, Gill A, Mehta S, Weinberg E, Alexander NB, Althuis K, Hoelscher A, Zhao L, Chen X, Burdzy A, Serper M. (2025) · DOI: 10.1097/hc9.0000000000000626